| Literature DB >> 29159145 |
Fahad Naeem1, Samiullah Khan2, Aamir Jalil1, Nazar Muhammad Ranjha1, Amina Riaz1, Malik Salman Haider1, Shoaib Sarwar1, Fareha Saher1, Samrin Afzal1.
Abstract
Introduction: The current work was aimed to design and synthesize novel crosslinked pH-sensitive gelatin/pectin (Ge/Pec) hydrogels using different polymeric ratios and to explore the effect of polymers and degree of crosslinking on dynamic, equilibrium swelling and in vitro release behavior of the model drug (Mannitol).Entities:
Keywords: Controlled delivery; Mannitol; Natural polymers; Stimuli responsive; Superabsorbent
Year: 2017 PMID: 29159145 PMCID: PMC5684509 DOI: 10.15171/bi.2017.21
Source DB: PubMed Journal: Bioimpacts ISSN: 2228-5652
Figure 1Feed Composition ratio of different formulations of Ge/Pec hydrogels
|
|
|
|
|
|
|
| S1 | 12.8 | 0.8 | 94.11/5.88 | 4.0 | 2.06 |
| S2 | 14.4 | 0.8 | 94.74/5.26 | 4.0 | 2.30 |
| S3 | 16.0 | 0.8 | 95.23/4.76 | 4.0 | 2.54 |
| S4 | 12.6 | 0.9 | 93.3/6.67 | 4.0 | 2.04 |
| S5 | 12.6 | 1.06 | 92.24/7.76 | 4.0 | 2.06 |
| S6 | 12.6 | 1.20 | 91.30/8.70 | 4.0 | 2.08 |
| S7 | 12.6 | 1.20 | 91.30/8.70 | 3.8 | 1.98 |
| S8 | 12.6 | 1.20 | 91.30/8.70 | 4.2 | 2.18 |
| S9 | 12.6 | 1.20 | 91.30/8.70 | 4.6 | 2.40 |
Figure 2
Figure 3
Figure 4
Figure 5Dynamic and equilibrium swelling study of Ge/Pec hydrogels
|
|
|
|
|
|
| |||||
|
|
|
|
|
|
|
|
|
| ||
| S1 | 94.11/5.88 | 3.312 | 12.51 | 2.69 | 3.82 | 2.056 | 3.21 | 2.52 | 3.96 | |
| S2 | 94.74/5.26 | 3.304 | 13.72 | 2.706 | 4.04 | 4 | 3.97 | 2.9 | 4.12 | |
| S3 | 95.23/4.76 | 4.093 | 14.32 | 3.082 | 4.43 | 3.1833 | 4.44 | 2.92 | 4.21 | |
| S4 | 93.3/6.67 | 3.496 | 12.35 | 2.877 | 3.82 | 2.53 | 3.70 | 3.11 | 4.01 | |
| S5 | 92.24/7.76 | 3.593 | 13.01 | 2.88 | 3.99 | 2.63 | 3.77 | 3.26 | 4.03 | |
| S6 | 91.30/8.70 | 3.315 | 14.66 | 2.839 | 4.08 | 2.71 | 3.94 | 3.145 | 4.13 | |
| S7 | 91.30/8.70 | 3.429 | 13.05 | 2.938 | 3.97 | 2.702 | 3.71 | 2.798 | 4.05 | |
| S8 | 91.30/8.70 | 3.352 | 13.79 | 2.826 | 3.83 | 2.652 | 3.57 | 2.75 | 4.01 | |
| S9 | 91.30/8.70 | 3.075 | 11.90 | 2.601 | 3.78 | 2.5 | 3.43 | 2.695 | 3.98 | |
Abbreviations: Q, dynamic swelling; Eq, equilibrium swelling.
Percent (%) mannitol released in different formulations of Ge/Pec hydrogels
|
|
|
|
|
| S1 | 80.02 | 50.21 | 60.04 |
| S2 | 82.15 | 50.21 | 60.11 |
| S3 | 81.15 | 50.37 | 60.41 |
| S7 | 81.55 | 50.87 | 60.91 |
| S8 | 80.95 | 49.97 | 60.11 |
| S9 | 80.42 | 49.43 | 59.71 |
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
% Gel fraction and Porosity of different samples of Ge/Pec hydrogels
|
|
|
|
|
|
| S1 | 94.11/5.88 | 4.0 | 83.11 | 30.14 |
| S2 | 94.74/5.26 | 4.0 | 84.64 | 39.12 |
| S3 | 95.23/4.76 | 4.0 | 85.43 | 44.5 |
| S4 | 93.3/6.67 | 4.0 | 78.19 | 19.89 |
| S5 | 92.24/7.76 | 4.0 | 79.01 | 22.98 |
| S6 | 91.30/8.70 | 4.0 | 80.577 | 26.79 |
| S7 | 91.30/8.70 | 3.8 | 79.57 | 25.11 |
| S8 | 91.30/8.70 | 4.2 | 82.75 | 21.77 |
| S9 | 91.30/8.70 | 4.6 | 84.37 | 17.68 |
Figure 17
Figure 18Flory-Huggins network parameters of Ge/Pec hydrogels
|
|
|
|
|
|
|
|
| S1 | 0.036467 | -0.5125 | 4713.664 | 94.60281 | 49.82584 | 0.159516 |
| S2 | 0.036238 | -0.51242 | 5129.1 | 93.95429 | 54.59144 | 0.096693 |
| S3 | 0.034381 | -0.51176 | 5139.356 | 93.42916 | 55.00805 | 0.080312 |
| S4 | 0.041956 | -0.51444 | 3526.781 | 95.37452 | 36.97823 | 0.149048 |
| S5 | 0.039419 | -0.51354 | 3710.133 | 96.46819 | 38.45965 | 0.130594 |
| S6 | 0.038888 | -0.51335 | 4442.316 | 97.42065 | 45.59932 | 0.129911 |
| S7 | 0.035458 | -0.51214 | 4570.259 | 96.78327 | 47.22158 | 0.135711 |
| S8 | 0.04245 | -0.51462 | 3234.571 | 98.05006 | 32.98897 | 0.192186 |
| S9 | 0.043457 | -0.51497 | 3184.885 | 99.40741 | 32.03871 | 0.221298 |
Effect of different contents of Ge on drug release kinetics of Ge/Pec hydrogels in buffer solutions of variable pH values using GA as crosslinking agent (4 wt% of Ge and Pec)
|
|
|
|
|
|
| |||
|
|
|
|
|
|
| |||
| S1 | 12.8 | 1.2 | 6.449 | 0.993 | 0.128 | 0.980 | 0.276 | 0.984 |
| 5.5 | 4.065 | 0.988 | 0.55 | 0.964 | 0.169 | 0.924 | ||
| 7.5 | 4.893 | 0.997 | 0.073 | 0.974 | 0.206 | 0.958 | ||
| S2 | 14.4 | 1.2 | 6.475 | 0.991 | 0.131 | 0.976 | 0.027 | 0.979 |
| 5.5 | 4.065 | 0.988 | 0.055 | 0.960 | 0.169 | 0.924 | ||
| 7.5 | 4.894 | 0.997 | 0.073 | 0.974 | 0.206 | 0.958 | ||
| S3 | 16.0 | 1.2 | 6.413 | 0.993 | 0.133 | 0.974 | 0.275 | 0.983 |
| 5.5 | 4.065 | 0.988 | 0.055 | 0.960 | 0.169 | 0.924 | ||
| 7.5 | 4.894 | 0.997 | 0.067 | 0.975 | 0.206 | 0.958 | ||
Effect of degree of crosslinking on drug release kinetics of Ge/Pec hydrogels in buffer solutions of variable pH values
|
|
|
|
|
|
| |||
|
|
|
|
|
|
| |||
| S7 | 3.8% | 1.2 | 6.419 | 0.994 | 0.116 | 0.978 | 0.273 | 0.970 |
| 5.5 | 3.744 | 0.983 | 0.048 | 0.957 | 0.155 | 0.912 | ||
| 7.5 | 4.635 | 0.993 | 0.065 | 0.971 | 0.194 | 0.940 | ||
| S8 | 4.2% | 1.2 | 6.635 | 0.994 | 0.135 | 0.972 | 0.279 | 0.986 |
| 5.5 | 4.061 | 0.987 | 0.055 | 0.960 | 0.169 | 0.924 | ||
| 7.5 | 4.891 | 0.997 | 0.073 | 0.974 | 0.206 | 0.959 | ||
| S9 | 4.6% | 1.2 | 6.591 | 0.995 | 0.119 | 0.964 | 0.277 | 0.967 |
| 5.5 | 3.740 | 0.983 | 0.048 | 0.957 | 0.155 | 0.912 | ||
| 7.5 | 4.658 | 0.994 | 0.065 | 0.973 | 0.195 | 0.942 | ||
Effect of variable contents of Ge on drug release mechanism of Ge/Pec hydrogels in buffer solutions of variable pH values using GA as crosslinking agent (4 wt% of Ge and Pec)
|
|
|
|
|
|
|
| S1 | 26 | 1.2 | 0.826 | 0.995 | Non-fickian |
| 5.5 | 0.930 | 0.990 | Non-fickian | ||
| 7.5 | 0.947 | 0.994 | Non-fickian | ||
| S2 | 32 | 1.2 | 0.782 | 0.988 | Non-fickian |
| 5.5 | 0.944 | 0.989 | Non-fickian | ||
| 7.5 | 0.946 | 0.994 | Non-fickian | ||
| S3 | 38 | 1.2 | 0.732 | 0.988 | Non-fickian |
| 5.5 | 0.930 | 0.990 | Non-fickian | ||
| 7.5 | 0.943 | 0.994 | Non-fickian |
Effect of degree of crosslinking on release mechanism of Ge/Pec hydrogels in buffer solutions of variable pH values
|
|
|
|
|
|
|
| S7 | 3.8% | 1.2 | 0.971 | 0.990 | Non-fickian |
| 5.5 | 0.959 | 0.980 | Non-fickian | ||
| 7.5 | 0.992 | 0.976 | Non-fickian | ||
| S8 | 4.2% | 1.2 | 0.880 | 0.993 | Non-fickian |
| 5.5 | 0.916 | 0.987 | Non-fickian | ||
| 7.5 | 0.906 | 0.992 | Non-fickian | ||
| S9 | 4.6% | 1.2 | 0.826 | 0.995 | Non-fickian |
| 5.5 | 0.930 | 0.990 | Non-fickian | ||
| 7.5 | 0.947 | 0.994 | Non-fickian |
Figure 19